Does DEGARELIX Cause Injection site mass? 118 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 118 reports of Injection site mass have been filed in association with DEGARELIX (FIRMAGON). This represents 3.1% of all adverse event reports for DEGARELIX.
118
Reports of Injection site mass with DEGARELIX
3.1%
of all DEGARELIX reports
2
Deaths
11
Hospitalizations
How Dangerous Is Injection site mass From DEGARELIX?
Of the 118 reports, 2 (1.7%) resulted in death, 11 (9.3%) required hospitalization.
Is Injection site mass Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DEGARELIX. However, 118 reports have been filed with the FAERS database.
What Other Side Effects Does DEGARELIX Cause?
Injection site pain (296)
Injection site erythema (246)
Hot flush (199)
Fatigue (195)
Injection site swelling (183)
Product storage error (177)
Pyrexia (170)
Off label use (128)
Asthenia (123)
Death (120)
What Other Drugs Cause Injection site mass?
EXENATIDE (3,506)
DUPILUMAB (2,243)
GLATIRAMER (2,172)
ETANERCEPT (2,101)
NALTREXONE (1,849)
TIRZEPATIDE (1,386)
LEUPROLIDE (1,359)
DULAGLUTIDE (1,319)
EVOLOCUMAB (1,254)
ADALIMUMAB (915)
Which DEGARELIX Alternatives Have Lower Injection site mass Risk?
DEGARELIX vs DELAFLOXACIN MEGLUMINE
DEGARELIX vs DELAMANID
DEGARELIX vs DELANDISTROGENE MOXEPARVOVEC-ROKL
DEGARELIX vs DELAVIRDINE
DEGARELIX vs DELORAZEPAM